Metabolic Risk Factors: Identifying Who May Benefit GLP-1 eligibility often depends on underlying metabolic risk rather than weight alone
Oral Wegovy (Oral Semaglutide) For those who prefer a daily pill over injections, oral Wegovy offers a pioneering approach as the first oral GLP-1 approved for weight loss management
It is not a drug, dietary supplement, cosmetic, or medical device, and is not for human or animal consumption
Recent research has shown that GLP-1s and MHT are a beneficial combination, with MHT actually amplifying the weight loss effects of certain GLP-1 medications
Foods like lean meat, veggies, or things with soluble fiber are easier to digest
My suspicion is that most people regain the weight because the treatment was short-term, focused on weight loss rather than developing better habits, and resulted in loss of muscle, which reduces your basal metabolic rate and makes you more likely to gain weight